June 03, 2020 Asco 2020 movers – cell therapy companies dominate the risers Adaptimmune and Allogene led numerous cell therapy companies higher over the Asco period, while Cytomx and Arvinas suffered the biggest losses.
May 14, 2020 Asco 2020 – abstract dump triggers first moves An early look at data from the huge cancer conference boosts Allogene and Immunogen, while Arvinas and Cytomx suffer.
